- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 627046, 13 pages
5-Lipoxygenase Deficiency Reduces Acetaminophen-Induced Hepatotoxicity and Lethality
1Department of Pathology, Biological Science Centre, State University of Londrina, Rodovia Celso Garcia Cid Pr 445, Km 380. Cx. Postal 6001, 86051-990 Londrina PR, Brazil
2Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Avenida Bandeirantes 3900, 14049-900 Ribeirão Preto, SP, Brazil
3Department of Pharmaceutical Sciences, Health Sciences Centre, State University of Londrina, Rodovia Celso Garcia Cid Pr 445, Km 380, Cx. Postal 10011, 86051-990 Londrina, PR, Brazil
Received 30 April 2013; Revised 4 September 2013; Accepted 6 September 2013
Academic Editor: Chun-Ming Wong
Copyright © 2013 Miriam S. N. Hohmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- B. Samuelsson, S.-E. Dahlen, and J. A. Lindgren, “Leukotrienes and lipoxins: structures, biosynthesis, and biological effects,” Science, vol. 237, no. 4819, pp. 1171–1176, 1987.
- C. D. Funk, “Prostaglandins and leukotrienes: advances in eicosanoid biology,” Science, vol. 294, no. 5548, pp. 1871–1875, 2001.
- A. W. Ford-Hutchinson, M. A. Bray, and M. V. Doig, “Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes,” Nature, vol. 286, no. 5770, pp. 264–265, 1980.
- M. Chen, B. K. Lam, A. D. Luster et al., “Joint tissues amplify inflammation and alter their invasive behavior via leukotriene B4 in experimental inflammatory arthritis,” Journal of Immunology, vol. 185, no. 9, pp. 5503–5511, 2010.
- F. G. Al-Amran, N. R. Hadi, and A. M. Hashim, “Leukotriene biosynthesis inhibition ameliorates acute lung injury following hemorrhagic shock in rats,” Journal of Cardiothoracic Surgery, vol. 6, no. 1, article no. 81, 2011.
- L. Alric, C. Orfila, N. Carrere et al., “Reactive oxygen intermediates and eicosanoid production by Kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4,” Inflammation Research, vol. 49, no. 12, pp. 700–707, 2000.
- E. Titos, J. Clària, A. Planagumà et al., “Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis,” The FASEB Journal, vol. 17, no. 12, pp. 1745–1747, 2003.
- Y. Takamatsu, K. Shimada, K. Chijiiwa, S. Kuroki, K. Yamaguchi, and M. Tanaka, “Role of leukotrienes on hepatic ischemia/reperfusion injury in rats,” Journal of Surgical Research, vol. 119, no. 1, pp. 14–20, 2004.
- E. Titos, J. Clària, A. Planagumà et al., “Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells,” Journal of Leukocyte Biology, vol. 78, no. 4, pp. 871–878, 2005.
- R. Horrillo, A. Planagumà, A. González-Périz et al., “Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor,” Journal of Pharmacology and Experimental Therapeutics, vol. 323, no. 3, pp. 778–786, 2007.
- L. F. Prescott, “Hepatotoxicity of mild analgesics,” British Journal of Clinical Pharmacology, vol. 10, supplement 2, pp. 375S–377S, 1980.
- A. M. Larson, J. Polson, R. J. Fontana et al., “Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study,” Hepatology, vol. 42, no. 6, pp. 1364–1372, 2005.
- D. G. N. Craig, C. M. Bates, J. S. Davidson, K. G. Martin, P. C. Hayes, and K. J. Simpson, “Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity,” British Journal of Clinical Pharmacology, vol. 71, no. 2, pp. 273–282, 2011.
- J. R. Mitchell, D. J. Jollow, and W. Z. Potter, “Acetaminophen induced hepatic necrosis. I. Role of drug metabolism,” Journal of Pharmacology and Experimental Therapeutics, vol. 187, no. 1, pp. 185–194, 1973.
- C. J. Patten, P. E. Thomas, R. L. Guy et al., “Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics,” Chemical Research in Toxicology, vol. 6, no. 4, pp. 511–518, 1993.
- D. J. Jollow, J. R. Mitchell, and W. Z. Potter, “Acetaminophen induced hepatic necrosis. II. Role of covalent binding in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 187, no. 1, pp. 195–202, 1973.
- J. R. Mitchell, D. J. Jollow, and W. Z. Potter, “Acetaminophen induced hepatic necrosis. IV. Protective role of glutathione,” Journal of Pharmacology and Experimental Therapeutics, vol. 187, no. 1, pp. 211–217, 1973.
- B. V. Martin-Murphy, M. P. Holt, and C. Ju, “The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice,” Toxicology Letters, vol. 192, no. 3, pp. 387–394, 2010.
- R. F. Schwabe, E. Seki, and D. A. Brenner, “Toll-Like Receptor Signaling in the Liver,” Gastroenterology, vol. 130, no. 6, pp. 1886–1900, 2006.
- P. Jeannin, S. Jaillon, and Y. Delneste, “Pattern recognition receptors in the immune response against dying cells,” Current Opinion in Immunology, vol. 20, no. 5, pp. 530–537, 2008.
- D. L. Laskin and K. J. Pendino, “Macrophages and inflammatory mediators in tissue injury,” Annual Review of Pharmacology and Toxicology, vol. 35, pp. 655–677, 1995.
- S. L. Michael, N. R. Pumford, P. R. Mayeux, M. R. Niesman, and J. A. Hinson, “Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species,” Hepatology, vol. 30, no. 1, pp. 186–195, 1999.
- R. A. Roberts, P. E. Ganey, C. Ju, L. M. Kamendulis, I. Rusyn, and J. E. Klaunig, “Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis,” Toxicological Sciences, vol. 96, no. 1, pp. 2–15, 2007.
- D. A. Valério, S. R. Georgetti, D. A. Magro et al., “Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production,” Journal of Natural Products, vol. 72, no. 11, pp. 1975–1979, 2009.
- Z.-X. Liu, D. Han, B. Gunawan, and N. Kaplowitz, “Neutrophil depletion protects against murine acetaminophen hepatotoxicity,” Hepatology, vol. 43, no. 6, pp. 1220–1230, 2006.
- A.-C. Dragomir, J. D. Laskin, and D. L. Laskin, “Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1,” Toxicology and Applied Pharmacology, vol. 253, no. 3, pp. 170–177, 2011.
- Y. Zhai, R. W. Busuttil, and J. W. Kupiec-Weglinski, “Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation,” American Journal of Transplantation, vol. 11, no. 8, pp. 1563–1569, 2011.
- H. Jaeschke, A. Farhood, and C. W. Smith, “Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo,” FASEB Journal, vol. 4, no. 15, pp. 3355–3359, 1990.
- H. Jaeschke, A. Farhood, and C. W. Smith, “Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism,” American Journal of Physiology, vol. 261, no. 6, pp. G1051–G1056, 1991.
- H. Yaman, E. Cakir, E. O. Akgul et al., “Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury,” Experimental and Toxicologic Pathology, vol. 65, no. 1-2, pp. 147–151, 2013.
- P. P. Bradley, D. A. Priebat, R. D. Christensen, and G. Rothstein, “Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker,” Journal of Investigative Dermatology, vol. 78, no. 3, pp. 206–209, 1982.
- C. D. Horinouchi, D. A. Mendes, S. Soley Bda, et al., “Combretum leprosum Mart. (Combretaceae): potential as an antiproliferative and anti-inflammatory agent,” Journal of EthNopharmacology, vol. 145, no. 1, pp. 311–319, 2013.
- J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, pp. 192–205, 1968.
- V. Katalinic, D. Modun, I. Music, and M. Boban, “Gender differences in antioxidant capacity of rat tissues determined by 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays,” Comparative Biochemistry and Physiology Part C, vol. 140, no. 1, pp. 47–52, 2005.
- H. Watanuki, K. Ota, A. C. M. A. R. Tassakka, T. Kato, and M. Sakai, “Immunostimulant effects of dietary Spirulina platensis on carp, Cyprinus carpio,” Aquaculture, vol. 258, no. 1–4, pp. 157–163, 2006.
- R. P. Guedes, L. Dal Bosco, C. M. Teixeira et al., “Neuropathic pain modifies antioxidant activity in rat spinal cord,” Neurochemical Research, vol. 31, no. 5, pp. 603–609, 2006.
- W. A. Verri Jr., A. T. G. Guerrero, S. Y. Fukada et al., “IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 7, pp. 2723–2728, 2008.
- V. Darias, S. Abdala, D. Martin-Herrera, M. Luisa Tello, and S. Vega, “CNS effects of a series of 1,2,4-triazolyl heterocarboxylic derivatives,” Pharmazie, vol. 53, no. 7, pp. 477–481, 1998.
- Y. Ishida, T. Kondo, T. Ohshima, H. Fujiwara, Y. Iwakura, and N. Mukaida, “A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury,” FASEB Journal, vol. 16, no. 10, pp. 1227–1236, 2002.
- T. Ezzat, D. K. Dhar, M. Malago, and S. W. M. Olde Damink, “Dynamic tracking of stem cells in an acute liver failure model,” World Journal of Gastroenterology, vol. 18, no. 6, pp. 507–516, 2012.
- L.-Q. Qin, Y. Wang, J.-Y. Xu, T. Kaneko, A. Sato, and P.-Y. Wang, “One-day dietary restriction changes hepatic metabolism and potentiates the hepatotoxicity of carbon tetrachloride and chloroform in rats,” Tohoku Journal of Experimental Medicine, vol. 212, no. 4, pp. 379–387, 2007.
- D. J. Antoine, D. P. Williams, A. Kipar, H. Laverty, and B. Kevin Park, “Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity,” Molecular Medicine, vol. 16, no. 11-12, pp. 479–490, 2010.
- J. Scholmerich, “Interleukin in acute pancreatitis,” Scandinavian Journal of Gastroenterology, Supplement, vol. 31, no. 219, pp. 37–42, 1996.
- M. Faurschou and N. Borregaard, “Neutrophil granules and secretory vesicles in inflammation,” Microbes and Infection, vol. 5, no. 14, pp. 1317–1327, 2003.
- M. E. Blazka, J. L. Wilmer, S. D. Holladay, R. E. Wilson, and M. I. Luster, “Role of proinflammatory cytokines in acetaminophen hepatotoxicity,” Toxicology and Applied Pharmacology, vol. 133, no. 1, pp. 43–52, 1995.
- C. Cover, J. Liu, A. Farhood et al., “Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity,” Toxicology and Applied Pharmacology, vol. 216, no. 1, pp. 98–107, 2006.
- W. A. Verri Jr., T. M. Cunha, S. H. Ferreira et al., “IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production,” European Journal of Immunology, vol. 37, no. 12, pp. 3373–3380, 2007.
- C. Ju, T. P. Reilly, M. Bourdi et al., “Protective role of kupffer cells in acetaminophen-induced hepatic injury in mice,” Chemical Research in Toxicology, vol. 15, no. 12, pp. 1504–1513, 2002.
- C. R. Gardner, J. D. Laskin, D. M. Dambach et al., “Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-α and interleukin-10,” Toxicology and Applied Pharmacology, vol. 184, no. 1, pp. 27–36, 2002.
- H.-M. Kang and M. E. Saltveit, “Antioxidant capacity of lettuce leaf tissue increases after wounding,” Journal of Agricultural and Food Chemistry, vol. 50, no. 26, pp. 7536–7541, 2002.
- K. Chan, X.-D. Han, and Y. W. Kan, “An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4611–4616, 2001.
- M. Takahashi, “Oxidative stress and redox regulation on in vitro development of mammalian embryos,” Journal of Reproduction and Development, vol. 58, no. 1, pp. 1–9, 2012.
- R. A. Gubitosi-Klug, R. Talahalli, Y. Du, J. L. Nadler, and T. S. Kern, “5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy,” Diabetes, vol. 57, no. 5, pp. 1387–1393, 2008.
- C. H. C. Serezani, D. M. Aronoff, S. Jancar, and M. Peters-Golden, “Leukotriene B4 mediates p47phox phosphorylation and membrane translocation in polyunsaturated fatty acid-stimulated neutrophils,” Journal of Leukocyte Biology, vol. 78, no. 4, pp. 976–984, 2005.
- N. Chiang, C. N. Serhan, S.-E. Dahlén et al., “The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo,” Pharmacological Reviews, vol. 58, no. 3, pp. 463–487, 2006.
- C. N. Serhan, “Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators,” Journal of Periodontology, vol. 79, no. 8, pp. 1520–1526, 2008.
- W. P. Beierschmitt, J. D. McNeish, R. J. Griffiths, A. Nagahisa, M. Nakane, and D. E. Amacher, “Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): studies in rats and 5-LO knockout mice,” Toxicological Sciences, vol. 63, no. 1, pp. 15–21, 2001.